ABTL0812

· Ability Pharmaceuticals SL

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABTL0812, covering 2015-07-02 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABTL0812 in Pancreatic Cancer [Phase 1, Phase 2]